FDAnews Device Daily Bulletin
Feb. 14, 2005 | Vol. 2 No. 31
Medical devicemaker Medtronic has begun warning doctors about some faulty batteries installed in a line of its implantable heart defibrillators.
Vital Needs International has announced that Joey Diagnostic, an advanced model of the Joey Umbilical Safety System, is ready for commercialization and transfer to a corporate partner.
Integra LifeSciences has announced that the first three HINTEGRA Total Ankle Prostheses, a product of Newdeal, have been implanted in Brazil -- the largest market for foot and ankle implants in South America and the focus of Newdeal's efforts on that continent.
I-Flow has announced that two recently published studies of postsurgical pain relief after hernia surgery will be featured at the annual American Hernia Society meeting in San Diego.
The New Zealand and Australian Governments have announced a firm operational date for the new Trans Tasman Therapeutic Products Agency of no later than July 1 next year, though it could start earlier.
Medical Services International has developed a new diagnostic test kit for diagnosing prostate cancer. The test is a one-step prostate specific antigen test (PSA).
Medwave has closed on more than $5.2 million of additional capital to help further fund the company's growth and continued development.
Medical Home Products has said it intends to acquire an existing Medicare diabetes company.
Zynex Medical has announced the commencement of a new clinical study for the use of its NeuroMove device for stroke patients at the Texas Institute for Rehabilitation and Research.
Molecular Devices has announced the introduction of IonWorks Quattro, a second-generation ion channel screening instrument with four times the throughput capability over its predecessor, the IonWorks HT.
Arthrosurface is banking $10.5 million in funding, as it develops what it calls a joint resurfacing system.
MedMira, a maker of rapid flow-through diagnostic technology, has signed a distribution agreement with ExporTrade of Boca Raton, Fla., who will represent MedMira in selected countries in the Caribbean, South and Central America, bringing to two the number of active distributors in the region.
eCardio Diagnostics, a provider of advanced technology cardiac arrhythmia monitoring, has appointed Larry Lawson to serve as president and chief executive officer.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.